SCHEMBL30281298

SCHEMBL30281298

NC(=O)c1ncnn1CCOC(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23989808 0.83 TP53 (0.30) —
SCHEMBL30281196 0.79 ABL1 (0.32) —
SCHEMBL30281185 0.76 HDAC1 (0.31) —
SCHEMBL30281273 0.75 CNR1 (0.32) —
SCHEMBL3473167 0.74 TSHR (0.33) —
SCHEMBL25745016 0.71 — —
SCHEMBL12498978 0.71 PDE4B (0.33) —
SCHEMBL30281277 0.71 PTGS2 (0.37) —
SCHEMBL30281208 0.70 PIK3CA (0.41) —
SCHEMBL30281146 0.68 PIK3CA (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4143195-A1 IMIDAZOPYRIDAZINES AS MODULATORS OF IL-17 Janssen Pharmaceutica NV (BE) 2023-03-08 — — EP disclosed
Send feedback